June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Investigation of the filtration surgery with FocalSeal® in rabbit’s eyes
Author Affiliations & Notes
  • Yukinori Harada
    Department of Ophthalmology, University of Occupational & Environmental Health, Kitakyushu, Japan
  • Tatsuo Nagata
    Department of Ophthalmology, University of Occupational & Environmental Health, Kitakyushu, Japan
  • Mikki Arai
    Arai Eye Clinic, Fukuoka, Japan
    Schepens Eye Research Institute, Harvard Medical School, Boston, MA
  • Akihiko Tawara
    Department of Ophthalmology, University of Occupational & Environmental Health, Kitakyushu, Japan
  • Footnotes
    Commercial Relationships Yukinori Harada, None; Tatsuo Nagata, None; Mikki Arai, None; Akihiko Tawara, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4782. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yukinori Harada, Tatsuo Nagata, Mikki Arai, Akihiko Tawara; Investigation of the filtration surgery with FocalSeal® in rabbit’s eyes. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4782. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: FocalSeal® (FS) is an absorbable polyethylene glycol based synthetic hydrogel. A blue-green light makes FS harden by photopolymerization. The aim of this study was to investigate the efficacy of the intra-operative using FS for glaucoma filtration surgery in rabbit’s eyes.

Methods: There were two groups in this study. The first group included 9 rabbits. The conjunctiva in the left eyes was incised from limbus and the sclera was revealed, and FS was spread above the sclera, and then, after photopolymerization the conjunctiva was closed. In the right eyes, the conjunctiva was incised and simply closed (control). In the other group (6 rabbits included), a fornix-based filtration surgery with silicone tube sutured under the scleral flap was done in the left eye of 6 rabbits. In 3 of them, the seat of hardened FS was placed over the filtration site. In the other 3 eyes, the seat was not placed. Intraocular pressure measurements and bleb evaluations using ultrasound biomicroscopy (UBM) were performed. Six eyes from 3 rabbits in the first group were each enucleated 2, 4, 6 weeks after the surgery. In the second group, the left eyes of 6 rabbits were enucleated 4 weeks after surgery. Histopathologic evaluations of the surgical area were done in all enucleated eyes.

Results: In the first group, FS was remained in the subconjunctival spaces with inflammatory cells 2 weeks after the surgery. There was no FS observed in 4 weeks after the surgery, although there was a small subconjunctival space. In 6 weeks after the surgery, there were more Masson trichrome staining-positive collagen deposits in the subconjunctival tissues in the control than in the FS treated eyes. In the second group, postoperative IOPs of the FS treated eyes were lower than that of non-treated eyes, although there was no significant difference. The subconjunctival filtration spaces were detected by both UBM and histopathology in the FS treated eyes, but not in the control eyes. There was no remarkable difference in the immunohistochemical staining by anti-α-SMA antibody between FS and control. By anti-Vimentin antibody staining, the connective tissues of the bleb in the control eyes stained stronger than those in the FS treated eyes.

Conclusions: FocalSeal® used in the subconjunctival space could be a useful adjunctive substance to keep the filtering route in glaucoma filtration surgerys in rabbits.

Keywords: 637 pathology: experimental • 421 anterior segment • 765 wound healing  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×